Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Read More

Overview

Feature Articles

Latest Lung Cancer News and Research

Global analysis reveals up to four in ten cancer cases could be prevented

Global analysis reveals up to four in ten cancer cases could be prevented

Most commercially insured patients live with chronic conditions

Most commercially insured patients live with chronic conditions

Integrated Monte Carlo and deep learning improve radiotherapy QA

Integrated Monte Carlo and deep learning improve radiotherapy QA

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

Time of radiotherapy can influence the effectiveness of cancer treatment

Time of radiotherapy can influence the effectiveness of cancer treatment

Study offers a practical strategy to enhance effectiveness of immune checkpoint inhibitors

Study offers a practical strategy to enhance effectiveness of immune checkpoint inhibitors

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

Trojan horse immunotherapy opens tumors to immune system attack

Trojan horse immunotherapy opens tumors to immune system attack

Cancer vaccines enter a new era of personalized immunotherapy

Cancer vaccines enter a new era of personalized immunotherapy

AI tool predicts metastatic risk in multiple cancers

AI tool predicts metastatic risk in multiple cancers

Understanding tumor growth patterns helps guide treatment after lung cancer

Understanding tumor growth patterns helps guide treatment after lung cancer

Newly discovered survival pathway explains stubborn EGFR-driven lung cancers

Newly discovered survival pathway explains stubborn EGFR-driven lung cancers

Lung cancer deaths leveling off for EU women, except in Spain

Lung cancer deaths leveling off for EU women, except in Spain

Expanded school tobacco prevention in California is linked to lower youth vaping and smoking

Expanded school tobacco prevention in California is linked to lower youth vaping and smoking

Cancer mortality drops 34% as treatments and early detection improve

Cancer mortality drops 34% as treatments and early detection improve

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer

Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer

Durvalumab extends survival in small cell lung cancer but raises cost concerns

Durvalumab extends survival in small cell lung cancer but raises cost concerns

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.